Two-Year epilepsy drug trial tests Long-Term safety
NCT ID NCT07238868
Summary
This study follows patients for up to two years to check the long-term safety and effectiveness of an experimental epilepsy drug called CB03-154. It includes 144 people with focal epilepsy who successfully finished an earlier trial. The goal is to see how well the drug controls seizures over time and monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alfred Health
RECRUITINGMelbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.